AISIO

AISIO

AISIO (Artificial Intelligence Services in Oncology). It is a Non-Profit Service that will offer Artificial Intelligence applications in Molecular ...

Read more
Rare-iD

RARE_iD

Our interest in neonatal pediatric screening is enhanced by the introduction of new molecular techniques. We are launching a new service, RARE-iD, ...

Read more
Μία Δεύτερη Γνώμη

A Second Opinion

Immunotherapy and Targeted Personalized Therapy are the promising new treatments in cancer, which result from the molecular profile of the tumor (...

Read more